References
- Atkins D, Ferrone S, Schmahl GE, et al. (2004). Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol 171:885–9
- Chun M. (2009). Time for global efforts with clinical trials for advanced cervical cancer patients. J Gynecol Oncol 20:201–2
- Garbi N, Tanaka S, Momburg F, Hammerling GJ. (2006). Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol 7:93–102
- Garland SM, Bhatla N, Ngan HY. (2012). Cervical cancer burden and prevention strategies: Asia Oceania perspective. Cancer Epidemiol Biomarkers Prev 21:1414–22
- Hasim A, Abudula M, Aimiduo R, et al. (2012). Post-transcriptional and epigenetic regulation of Antigen Processing Machinery (APM) components and HLA-I in cervical cancers from Uighur women. PLoS One 7:e44952
- Igney FH, Krammer PH. (2002). Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol 71:907–20
- Kirkegaard T, Edwards J, Tovey S, et al. (2006). Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 48:787–94
- Leys CM, Nomura S, LaFleur BJ, et al. (2007). Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery 141:41–50
- Lindquist JA, Hammerling GJ, Trowsdale J. (2001). ER60/ERp57 forms disulfide-bonded intermediates with MHC class I heavy chain. FASEB J 15:1448–50
- Lindquist JA, Jensen ON, Mann M, Hammerling GJ. (1998). ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J 17:2186–95
- Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–8
- Mehta AM, Jordanova ES, Kenter GG, et al. (2008). Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 57:197–206
- Moody CA, Laimins LA. (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550–60
- Noh KH, Kim BW, Song KH, et al. (2012). Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest 122:4077–93
- Ogino T, Bandoh N, Hayashi T, et al. (2003). Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res 9:4043–51
- Radcliffe CM, Diedrich G, Harvey DJ, et al. (2002). Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J Biol Chem 277:46415–23
- Seliger B, Wollscheid U, Momburg F, et al. (2000). Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin. Tissue Antigens 56:327–36